Search Results

Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole

Authors: Grün, Barbara; Krautter, Stefanie; Riedel, Klaus-Dieter; Mikus, Gerd

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 712-720(9)

Publisher: Blackwell Publishing

Anabolic-androgenic steroid dependence: an emerging disorder

Authors: Kanayama, Gen; Brower, Kirk J.; Wood, Ruth I.; Hudson, James I.; Pope Jr, Harrison G.

Source: Addiction, Volume 104, Number 12, December 2009 , pp. 1966-1978(13)

Publisher: Blackwell Publishing

Buprenorphine/dipotassium clorazepate/naltrexone: Interaction between buprenorphine and naltrexone leading to opioid withdrawal symptoms, and dipotassium clorazepate-induced anterograde amnesia: case report

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 10-11(2)

Publisher: Adis International

Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland

Authors: Mitchell, Shannon Gwin; Kelly, Sharon; Brown, Barry; Reisinger, Heather Schacht; Peterson, James; Ruhf, Adrienne; Agar, Michael; O'Grady, Kevin; Schwartz, Robert

Source: American Journal on Addictions, Volume 18, Number 5, September 2009 , pp. 346-355(10)

Publisher: Informa Healthcare

Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?

Authors: Rubovitch, Vardit; Pick, Chaim G; Sarne, Yosef

Source: Addiction Biology, Volume 14, Number 4, October 2009 , pp. 438-446(9)

Publisher: Blackwell Publishing

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

Authors: Orman, Jennifer S.; Keating, Gillian M.

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 899-902(4)

Publisher: Adis International

A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification

Authors: Madlung-Kratzer, Ekkehard; Spitzer, Berhard; Brosch, Renate; Dunkel, Dirk; Haring, Christian

Source: Addiction, Volume 104, Number 9, September 2009 , pp. 1549-1557(9)

Publisher: Blackwell Publishing

Clonidine in Perioperative Medicine and Intensive Care Unit: More Than An Anti-Hypertensive Drug

Authors: Gregoretti, C.; Moglia, B.; Pelosi, P.; Navalesi, P.

Source: Current Drug Targets, Volume 10, Number 8, August 2009 , pp. 799-814(16)

Publisher: Bentham Science Publishers

Naltrexone: Opioid withdrawal symptoms in a patient abusing oxycodone: case report

Source: Reactions, Volume 1, Number 1261, 2009-07-18 , pp. 22-22(1)

Publisher: Adis International

Prevalence and correlates of epileptic seizure in substance-abusing subjects

Authors: Mattoo, Surendra K.; Singh, Shubh M.; Bhardwaj, Rahul; Kumar, Suresh; Basu, Debasish; Kulhara, Parmanand

Source: Psychiatry and Clinical Neurosciences, Volume 63, Number 4, August 2009 , pp. 580-582(3)

Publisher: Blackwell Publishing

Alterations in pituitary-thyroid axis function among opioid-dependent subjects after acute and protracted abstinence

Authors: Zhang, Guo-fu; Tang, Yi-lang; Smith, Alicia K.; Liu, Zhen-qi; Sheng, Li-xia; Chi, Yong; Du, Wan-jun; Guo, Song; Jiang, Zuo-ning; Xiao, Le; Zhang, Hong-xi; Luo, Xiao-nian

Source: Addiction Biology, Volume 14, Number 3, July 2009 , pp. 310-314(5)

Publisher: Blackwell Publishing

Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: A rural and metropolitan comparison

Authors: TETSTALL, Emma; LIU, Anthony Jun Wing; AN, Ethan Ikhyun; CANALESE, Joe; NANAN, Ralph

Source: Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 49, Number 3, June 2009 , pp. 279-284(6)

Publisher: Blackwell Publishing

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study*

Authors: Hale, Martin; Upmalis, David; Okamoto, Akiko; Lange, Claudia; Rauschkolb, Christine

Source: Current Medical Research and Opinion, Volume 25, Number 5, May 2009 , pp. 1095-1104(10)

Publisher: Informa Healthcare

Naltrexone: Opioid withdrawal symptoms in a patient receiving concomitant opioids: case report

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 29-29(1)

Publisher: Adis International

Functional Interaction Between Purinergic System and Opioid Withdrawal: In Vitro Evidence

Authors: Capasso, Anna; Gallo, Chiara

Source: Current Drug Safety, Volume 4, Number 2, May 2009 , pp. 97-102(6)

Publisher: Bentham Science Publishers

Buprenorphine/Naloxone: A Review of its Use in the Treatment of Opioid Dependence

Authors: Orman, Jennifer S.; Keating, Gillian M.

Source: Drugs, Volume 69, Number 5, 26 March 2009 , pp. 577-607(31)

Publisher: Adis International

Comprehensive Inpatient Treatment of Refractory Chronic Daily Headache

Authors: Lake, Alvin E.; Saper, Joel R.; Hamel, Robert L.

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 4, April 2009 , pp. 555-562(8)

Publisher: Blackwell Publishing

Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market

Authors: Bruce, R. Douglas; Govindasamy, Sumathi; Sylla, Laurie; Kamarulzaman, Adeeba; Altice, Frederick

Source: The American Journal of Drug and Alcohol Abuse, Volume 35, Number 2, March 2009 , pp. 68-72(5)

Publisher: Informa Healthcare

Shadows across μ-Star? Constitutively active μ-opioid receptors revisited

Author: Connor, Mark

Source: British Journal of Pharmacology, Volume 156, Number 7, April 2009 , pp. 1041-1043(3)

Publisher: Blackwell Publishing

Neutral antagonist activity of naltrexone and 6β-naltrexol in naïve and opioid-dependent C6 cells expressing a µ-opioid receptor

Authors: Divin, MF; Bradbury, FA; Carroll, FI; Traynor, JR

Source: British Journal of Pharmacology, Volume 156, Number 7, April 2009 , pp. 1044-1053(10)

Publisher: Blackwell Publishing